Valuation: Cutera

Market Cap 7.12M 6.19M 5.78M 5.31M 10.01M 679M 10.18M 68.15M 26.69M 339M 26.76M 26.17M 1.12B P/E 2022
-10.1x
P/E 2023 -0.43x
Enterprise Value 295M 257M 240M 220M 415M 28.16B 422M 2.83B 1.11B 14.04B 1.11B 1.09B 46.32B EV / Sales 2022
3.89x
EV / Sales 2023 1.69x
Free-Float
-
Yield 2022 *
-
Yield 2023 -
3 years 0
Extreme 0.005
18.83
5 years 0
Extreme 0.005
74.38
10 years 0
Extreme 0.005
74.38
Manager TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 60 05/05/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 57 01/07/2023
Director/Board Member 67 01/05/2023
Director/Board Member 49 19/05/2023
Date Insider Type Main position Quantity % Market Cap.
13/2/25 Tax

General Counsel

623 0.0031%
7/2/25 Tax

Chief Executive Officer

4,620 0.0229%
1/2/25 Tax

Chief Financial Officer

22 0.0001%

Financials

2022 2023
Net sales 252M 219M 205M 188M 354M 24.06B 361M 2.41B 946M 12B 948M 927M 39.57B 212M 185M 172M 158M 298M 20.24B 303M 2.03B 796M 10.09B 798M 780M 33.29B
Net income -82.34M -71.56M -66.81M -61.33M -116M -7.85B -118M -788M -309M -3.91B -309M -302M -12.91B -163M -142M -132M -121M -229M -15.52B -233M -1.56B -610M -7.74B -612M -598M -25.53B
Net Debt 115M 99.61M 93M 85.38M 161M 10.92B 164M 1.1B 429M 5.45B 431M 421M 17.97B 288M 251M 234M 215M 405M 27.48B 412M 2.76B 1.08B 13.7B 1.08B 1.06B 45.2B
Logo Cutera
Cutera, Inc. is a provider of aesthetic and dermatology solutions for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured Secret systems and consumables. It markets various system platforms, such as AviClear, enlighten, excel V/V+, excel HR, truSculpt, Secret PRO, Secret DUO Secret RF, xeo, and xeo+, each of which enables medical practitioners to perform procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. With its xeo platform, practitioners can purchase customized systems with a variety of the Company’s multi-technology applications. Each of the Company’s products consists of a control console and one or more hand pieces, depending on the model.
Employees
430
Sector
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. CUTR Stock